Cargando…
Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
OBJECTIVE: To determine the effect of adjunctive quetiapine therapy on the sleep architecture of patients with bipolar or unipolar depression. METHODS: This is a prospective, single-blind, repeated measures polysomnographic study. Sleep architecture was analyzed by overnight polysomnography, and sub...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938299/ https://www.ncbi.nlm.nih.gov/pubmed/20856913 |
_version_ | 1782186592055590912 |
---|---|
author | Gedge, Laura Lazowski, Lauren Murray, David Jokic, Ruzica Milev, Roumen |
author_facet | Gedge, Laura Lazowski, Lauren Murray, David Jokic, Ruzica Milev, Roumen |
author_sort | Gedge, Laura |
collection | PubMed |
description | OBJECTIVE: To determine the effect of adjunctive quetiapine therapy on the sleep architecture of patients with bipolar or unipolar depression. METHODS: This is a prospective, single-blind, repeated measures polysomnographic study. Sleep architecture was analyzed by overnight polysomnography, and subjective sleep quality was measured using the Pittsburgh Sleep Quality Index. The Hamilton Rating Scale for Depression, Montgomery Asberg Depression Rating Scale, Young Mania Rating Scale, and Clinical Global Impression-Severity Scale were employed to quantify changes in illness severity with adjunctive quetiapine treatment. Polysomnographs and clinical measures were administered at baseline, after 2–4 days of treatment, and after 21–28 days of quetiapine treatment. The average dose of quetiapine was 155 mg, ranging from 100–200 mg. RESULTS: Adjunctive quetiapine therapy did not significantly alter sleep efficiency, sleep continuity, or Pittsburgh Sleep Quality Index scores. Respiratory Disturbance Index and percentage of total time in rapid eye movement (REM) sleep significantly decreased and the percentage of total time in non-REM sleep, and duration of Stage 2 and non-REM sleep significantly increased after 2–4 days of quetiapine treatment. Illness severity significantly decreased over time. CONCLUSIONS: Adjunctive quetiapine treatment alters sleep architecture in patients with major depressive disorder or bipolar disorder, which may partially explain its early antidepressant properties. Changes in sleep architecture are more robust and significant within two to four days of starting treatment. |
format | Text |
id | pubmed-2938299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-29382992010-09-20 Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression Gedge, Laura Lazowski, Lauren Murray, David Jokic, Ruzica Milev, Roumen Neuropsychiatr Dis Treat Original Research OBJECTIVE: To determine the effect of adjunctive quetiapine therapy on the sleep architecture of patients with bipolar or unipolar depression. METHODS: This is a prospective, single-blind, repeated measures polysomnographic study. Sleep architecture was analyzed by overnight polysomnography, and subjective sleep quality was measured using the Pittsburgh Sleep Quality Index. The Hamilton Rating Scale for Depression, Montgomery Asberg Depression Rating Scale, Young Mania Rating Scale, and Clinical Global Impression-Severity Scale were employed to quantify changes in illness severity with adjunctive quetiapine treatment. Polysomnographs and clinical measures were administered at baseline, after 2–4 days of treatment, and after 21–28 days of quetiapine treatment. The average dose of quetiapine was 155 mg, ranging from 100–200 mg. RESULTS: Adjunctive quetiapine therapy did not significantly alter sleep efficiency, sleep continuity, or Pittsburgh Sleep Quality Index scores. Respiratory Disturbance Index and percentage of total time in rapid eye movement (REM) sleep significantly decreased and the percentage of total time in non-REM sleep, and duration of Stage 2 and non-REM sleep significantly increased after 2–4 days of quetiapine treatment. Illness severity significantly decreased over time. CONCLUSIONS: Adjunctive quetiapine treatment alters sleep architecture in patients with major depressive disorder or bipolar disorder, which may partially explain its early antidepressant properties. Changes in sleep architecture are more robust and significant within two to four days of starting treatment. Dove Medical Press 2010-09-07 2010 /pmc/articles/PMC2938299/ /pubmed/20856913 Text en © 2010 Gedge et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Gedge, Laura Lazowski, Lauren Murray, David Jokic, Ruzica Milev, Roumen Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression |
title | Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression |
title_full | Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression |
title_fullStr | Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression |
title_full_unstemmed | Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression |
title_short | Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression |
title_sort | effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938299/ https://www.ncbi.nlm.nih.gov/pubmed/20856913 |
work_keys_str_mv | AT gedgelaura effectsofquetiapineonsleeparchitectureinpatientswithunipolarorbipolardepression AT lazowskilauren effectsofquetiapineonsleeparchitectureinpatientswithunipolarorbipolardepression AT murraydavid effectsofquetiapineonsleeparchitectureinpatientswithunipolarorbipolardepression AT jokicruzica effectsofquetiapineonsleeparchitectureinpatientswithunipolarorbipolardepression AT milevroumen effectsofquetiapineonsleeparchitectureinpatientswithunipolarorbipolardepression |